Keurig Dr Pepper (KDP) recently reaffirmed its quarterly dividend at US$0.23 per share, payable on July 10, 2026, following Q1 revenue growth of over 9% and updated full year expectations.

The reaffirmed dividend and Q1 revenue update come as the stock’s share price return is up 8.9% year to date, while the 1 year total shareholder return is down 6.1%. This suggests improving short term momentum against a softer longer term outcome.

If you are comparing KDP with other opportunities in the market, this is a good moment to broaden your search and check out 20 top founder-led companies

The mix of an 8.9% year to date share price gain, a 6.1% decline in 1 year total return, and an indicated intrinsic discount of about 50% sets up a key question for you: is KDP undervalued or already pricing in future growth?

Price-to-Earnings of 22.4x: Is it justified?

Keurig Dr Pepper is trading on a P/E of 22.4x, which screens as good value against its own fair P/E estimate, but looks expensive against the broader beverage industry.

The P/E ratio compares the current share price with earnings per share. At 22.4x, the market is paying $22.40 for every $1 of annual earnings. For a consumer beverages group with established brands and positive earnings, this is a common way investors benchmark what they are paying for current and future profit streams.

Here, the SWS analysis suggests a fair P/E of 23.9x for KDP, which is slightly higher than the current 22.4x. That implies the market price is sitting below the level the fair ratio model points to, while still standing well above the 17.3x average for the global beverage industry. Against direct peers, where the average P/E is 50.3x, KDP also screens as lower rated. This could signal that the market is assigning a more moderate earnings outlook compared to that group, even though it is already pricing the stock richer than the wider industry.

Result: Price-to-Earnings of 22.4x (UNDERVALUED)

However, this picture can change quickly if revenue, currently US$16.9b, or net income of US$1.8b fall short of expectations, or if the wider beverage sector is derated.

Another View: Cash Flows Point To Deeper Value

While the 22.4x P/E ratio suggests Keurig Dr Pepper is near its 23.9x fair ratio, the SWS DCF model presents a wider value gap. Compared with the current $30.20 share price, the DCF fair value estimate of $60.73 indicates the stock appears meaningfully undervalued on cash flows.

This difference between earnings-based and cash-flow-based views leaves a key judgment call: which lens is more appropriate for a mature beverages business with US$16.9b in revenue and US$1.8b in net income?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Keurig Dr Pepper for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 48 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Mixed messages on value and momentum can be useful, but they only matter if you put them in context for your own goals and risk tolerance. Take a moment to review the full breakdown of the company's risks and rewards in 2 key rewards and 1 important warning sign

Looking for more investment ideas?

Do not stop with a single stock when you can quickly test fresh ideas against your goals using focused screeners built around quality, value, and resilience.

• Target resilient balance sheets by checking companies highlighted in the solid balance sheet and fundamentals stocks screener (45 results).
• Hunt for potential value opportunities using the 48 high quality undervalued stocks to compare price with fundamentals in a structured way.
• Spot under-the-radar opportunities before the crowd by reviewing the screener containing 22 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.